Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
Recruiting · NCT03731130 · Observational (researchers observe without assigning treatment) · Lead sponsor: Ludwig-Maximilians - University of Munich
View the official record on ClinicalTrials.gov →Interventions studied
EORTC QLQ C30EORTC QLQ CR29
What this trial is about
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional Outcome, oncological outcome and toxicity in patients treated with neoadjuvant short term radiation or long-term chemoradiation followed by surgery
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- histologically proven rectal Cancer without distant metastases
- indication for neoadjuvant Radiation or chemoradiation therapy according to multidiciplinary Evaluation
- age \>=18 years
- written informed consent
- ability to answer the standardized questionaires according to the treating physician
Exclusion criteria
- age \< 18 years
- prior systemic therapy with regard to rectal Cancer
- distant metastasis
- second malignancy
Where it is running
1 location listed.
- Department of Radiation Oncology, University Hospital, LMU Munich - Munich, Bavaria, Germany